NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAMS E-149-1999-0-US-03 Methods for Ameliorating Icthyosiform Skin Diseases US CON 10/023,275 6852686 Expired PDF
NCI E-251-2000-0-PCT-02 Telomerase Immortalized Epithelial Cell Lines PCT PCT PCT/US01/47755 Abandoned
NCI E-278-1998-0-PCT-02 Benzoylalkylindolepyridinium Compounds and Pharmaceutical Compositions Comprising Such Compounds PCT PCT PCT/US01/48311 Abandoned
NCI E-091-2001-0-PCT-02 Benzoylalkylindolepyridinium Compounds And Pharmaceutical Compositions Comprising Such Compounds PCT PCT PCT/US01/48310 Abandoned
NCI E-091-2001-1-US-01 Benzoylalkylindolepyridinium Compounds And Pharmaceutical Compositions Comprising Such Compounds US ORD 10/017,323 Abandoned
NCI E-206-2003-0-US-01 Gene Expression Is Silenced In Chromosomal Amplicons In Colorectal Carcinomas (CRC) US 60/340,124 Abandoned
NINDS E-127-2008-0-US-01 Method For MR/NMR Imaging US 60/339,668 Abandoned
NIDCR E-066-1996-0-AU-05 AAV4 VECTOR AND USES THEREOF AU DIV 97210/01 Abandoned
NIAID E-051-2002-0-US-01 Method of Controlling Inflammation US 60/340,772 Abandoned
NIMH E-123-1999-0-US-03 PARATHYROID HORMONE RECEPTOR LIGANDS US National Stage 10/014,162 7122624 Abandoned PDF
NCI E-237-2000-0-AU-06 Compositions And Methods related to The Minn 1 Tumor Suppressor Gene And Protein AU National Stage 2002230885 Abandoned
NIDCR E-127-1995-0-US-02 ISOLATION AND USE OF TISSUE GROWTH-INDUCING FRZB PROTEIN US CON 10/014,055 6884871 Abandoned PDF
NCI E-237-2000-0-PCT-02 Compositions And Methods related to The Minn 1 Tumor Suppressor Gene And Protein PCT PCT PCT/US01/48514 Expired
NCI E-095-2002-0-PCT-03 Nucleic Acids of the Human ABCA5, ABCA6, ABCA9 and ABCA10 Genes, Vectors Containing Such Nucleic Acids and Uses Thereof PCT PCT PCT/US01/15401 Expired
NCI E-095-2002-0-US-04 Nucleic Acids of the Human ABCA5, ABCA6, ABCA9 and ABCA10 Genes, Vectors Containing Such Nucleic Acids and Uses Thereof US ORD 10/005,338 Abandoned
NCI E-095-2002-0-JP-06 Nucleic Acids of the Human ABCA5, ABCA6, ABCA9 and ABCA10 Genes, Vectors Containing Such Nucleic Acids and Uses Thereof JP National Stage 2002-548175 Abandoned
NCI E-095-2002-0-EP-05 Nucleic Acids of the Human ABCA5, ABCA6, ABCA9 and ABCA10 Genes, Vectors Containing Such Nucleic Acids and Uses Thereof EP National Stage 01999665.1 Abandoned
NCI E-237-2000-0-EP-04 Compositions And Methods related to The Minn 1 Tumor Suppressor Gene And Protein EP National Stage 01991139.5 Abandoned
NCI E-317-2001-0-US-01 Compounds to Treat HIV Infection And Aids. US 60/339,137 Abandoned
NIDDK E-166-2001-0-US-01 HGC-1 A Gene Encoding a Member of The Olfactomedin-Related Protein Family US 60/338,759 Abandoned
NCI E-029-2002-0-US-01 PEPTIDE T STIMULATES CTL RESPONSES US 60/338,971 Abandoned
NCI E-138-2002-0-US-01 Rapid Methods and Devices for Detecting and Identifying Biological Agents US 60/339,159 Abandoned
CC E-244-2000-1-US-01 Endoluminal Radiofrequency Cauterization System US ORD 10/017,619 6676657 Expired PDF
NCI E-181-1999-0-NL-13 A Combined Growth Factor-Deleted and Thymidine Kinase-Deleted Vaccinia Virus Vector NL EP 00939374.5 Expired
NCI E-181-1999-0-DE-10 A Combined Growth Factor-Deleted and Thymidine Kinase-Deleted Vaccinia Virus Vector DE EP 00939374.5 Expired
NCI E-181-1999-0-FR-11 A Combined Growth Factor-Deleted and Thymidine Kinase-Deleted Vaccinia Virus Vector FR EP 00939374.5 Expired
NCI E-181-1999-0-CH-09 A Combined Growth Factor-Deleted and Thymidine Kinase-Deleted Vaccinia Virus Vector CH EP 00939374.5 Expired
NCI E-181-1999-0-GB-12 A Combined Growth Factor-Deleted and Thymidine Kinase-Deleted Vaccinia Virus Vector GB EP 00939374.5 Expired
NCI E-086-2004-0-JP-15 Pharmaceutical Compositions Of Fenretinide Having Increased Bioavailability And Methods Of Using Them JP National Stage 2002-559023 Expired
NCI E-086-2004-0-SE-14 PHARMACEUTICAL COMPOSITIONS OF FENRETINIDE HAVING INCREASED BIOAVAILABILITY AND METHODS OF USING THE SAME SE EP 01989170.4 Expired
NCI E-086-2004-0-GB-10 PHARMACEUTICAL COMPOSITIONS OF FENRETINIDE HAVING INCREASED BIOAVAILABILITY AND METHODS OF USING THE SAME GB EP 01989170.4 Expired
NCI E-086-2004-0-CH-05 PHARMACEUTICAL COMPOSITIONS OF FENRETINIDE HAVING INCREASED BIOAVAILABILITY AND METHODS OF USING THE SAME CH EP 01989170.4 Expired
NCI E-086-2004-0-DK-07 PHARMACEUTICAL COMPOSITIONS OF FENRETINIDE HAVING INCREASED BIOAVAILABILITY AND METHODS OF USING THE SAME DK EP 01989170.4 Expired
NCI E-086-2004-0-ES-08 PHARMACEUTICAL COMPOSITIONS OF FENRETINIDE HAVING INCREASED BIOAVAILABILITY AND METHODS OF USING THE SAME ES EP 01989170.4 Expired
NCI E-086-2004-0-NL-13 PHARMACEUTICAL COMPOSITIONS OF FENRETINIDE HAVING INCREASED BIOAVAILABILITY AND METHODS OF USING THE SAME NL EP 01989170.4 Expired
NCI E-086-2004-0-DE-06 PHARMACEUTICAL COMPOSITIONS OF FENRETINIDE HAVING INCREASED BIOAVAILABILITY AND METHODS OF USING THE SAME DE EP 01989170.4 Expired
NCI E-086-2004-0-FR-09 PHARMACEUTICAL COMPOSITIONS OF FENRETINIDE HAVING INCREASED BIOAVAILABILITY AND METHODS OF USING THE SAME FR EP 01989170.4 Expired
NCI E-086-2004-0-IE-11 PHARMACEUTICAL COMPOSITIONS OF FENRETINIDE HAVING INCREASED BIOAVAILABILITY AND METHODS OF USING THE SAME IE EP 01989170.4 Expired
NCI E-086-2004-0-IT-12 PHARMACEUTICAL COMPOSITIONS OF FENRETINIDE HAVING INCREASED BIOAVAILABILITY AND METHODS OF USING THE SAME IT EP 01989170.4 Expired
NCI E-086-2004-0-EP-04 PHARMACEUTICAL COMPOSITIONS OF FENRETINIDE HAVING INCREASED BIOAVAILABILITY AND METHODS OF USING THE SAME EP National Stage 01989170.4 Expired
NCI E-086-2004-0-US-02 Pharmaceutical Compositions Of Fenretinide Having Increased Bioavailability And Methods Of Using Them US ORD 10/010,914 7169819 Expired PDF
NCI E-086-2004-0-PCT-03 Pharmaceutical Compositions Of Fenretinide Having Increased Bioavailability And Methods Of Using Them PCT PCT PCT/US2001/465548 Expired
NHLBI E-200-2000-0-PCT-02 Accelerated Magnetic Resonance Imaging PCT PCT PCT/US2001/046949 Expired
NHLBI E-200-2000-0-EP-03 Accelerated Magnetic Resonance Imaging EP National Stage 01996151.5 Abandoned
NIAID E-125-2001-0-PCT-01 Novel Spore Wall Proteins and Genes from Microsporidia PCT PCT PCT/US01/47182 Abandoned
NHLBI E-232-1994-0-US-03 CHIRAL SEPARATION OF ENANTIOMERS BY HIGH-SPEED COUNTERCURRENT CHROMATOGRAPHY US DIV 10/005,847 6503398 Abandoned PDF
NIAID E-017-2001-0-AU-07 Monoclonal Antibodies Specific for the E2 Glycoprotein of Hepatitis C Virus and Their Use in the Diagnosis, Treatment, and Prevention of Hepatitis C AU National Stage 2002243259 Abandoned
NCI E-081-1999-2-US-01 Redox-stable, Non-Phosphorylated Cyclic Peptide Inhibitors of SH2 Domain Binding to Target Protein, Conjugates Thereof, Compositions and Methods of Synthesis and Use US CIP 09/998,350 6951915 Expired PDF
NCI E-287-2000-0-PCT-02 Cell-Free Assembly of Lentiviral Capsids PCT PCT PCT/US01/46919 Abandoned
NIAID E-017-2001-0-PCT-02 Monoclonal Antibodies Specific for the E2 Glycoprotein of Hepatitis C Virus and Their Use in the Diagnosis, Treatment, and Prevention of
Hepatitis C 		PCT PCT PCT/US01/45221 Abandoned